C’est une nouvelle génération de Femmes. Des femmes qui se dépassent, courent plus vite, font ce kilomètre de plus pour être meilleures qu’elles ne l’ont jamais été. Elles investissent leurs parcs, leurs villes et célèbrent les sensations que le sport leur procure.
Cet été Nike a mis au défi plusieurs milliers de filles dans les plus grandes villes d’Europe et les a rassemblées lors de la course We Own The Night, une expérience de sport unique. Début 2014 les limites ont été repoussées et de nouveaux objectifs ont été atteints.
Pour visualiser le communiqué multimédia, rendez-vous sur : http://www.multivu.com/players/fr/72762552-nike-inspire-les-femmes-a-travers-europe/
Music video by Newsboys performing God\'s Not Dead (Official Music Video). (P) (C) 2012 Inpop Records. All rights reserved. Unauthorized reproduction is a violation of applicable laws. Manufactured by EMI Christian Music Group,
On the eve of World Cancer Day 2015, amidst the ongoing cost-of-cancer-care debate, PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative, is launching the PACE Continuous Innovation Indicators™ (CII). CII is the first evidence-based, customizable online tool to review progress against cancer over time—initially covering 12 cancer types. The purpose of the tool is to inform public policy reforms and other efforts to accelerate continuous innovation against cancer.
“We have seen tremendous progress in cancer treatment and care during the past decades, and continuous innovation, with one discovery building on another, is responsible for most of it,” said John C. Lechleiter, Ph.D., Chairman, President, and Chief Executive Officer of Eli Lilly and Company (NYSE:LLY). “To keep the momentum going, we need policies that support continuous innovation, but first we need a deeper understanding of the innovations that have occurred, and where we need to be.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7419451-eli-lilly-oncology-pace/
Honda will launch the new Civic at the IAA Frankfurt Motor Show in September. In the build-up to the reveal of the new Civic, Honda is releasing a series of short form films detailing its development. Developed specifically for the European market, the new Civic will be offered exclusively as a five-door hatchback and will compete in the C-segment. It will reach European showrooms in early 2012.
To view Multimedia News Release, go to http://www.multivu.com/players/English/51356-honda-motor-europe/
17.6 billion. That’s how many times U.S. shoppers visited brick-and-mortar stores during the 2013 holiday shopping season. That’s a lot of purchases – and a lot of receipts changing hands. Holiday sales are expected to rise 4.1 percent this November and December, meaning even more shoppers will be visiting stores and receiving gift receipts.
Just in time for the 2014 holiday shopping rush, a new receipt paper from Appvion, Inc., made with vitamin C instead of phenols like bisphenol A (BPA) and bisphenol S (BPS), is available to stores nationwide. Now shoppers can focus on finding that perfect gift instead of worrying about phenols in receipts they might receive.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7362451-appvion-launches-first-thermal-alpha-free-receipt-paper-using-vitamin-c-for-2014-holiday-shopping-season/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
The National WWII Museum today opened its newest permanent exhibit: Richard C. Adkerson & Freeport-McMoRan Foundation Road to Tokyo: Pacific Theater Galleries. Retracing the grueling trail that led from Pearl Harbor to Tokyo Bay, Road to Tokyo explores the evolving strategy for fighting relentless Japanese forces in Asia and the Pacific, examining cultural differences, logistical challenges and the staggering range of extreme conditions that confronted American military forces in Asia and the Pacific.
Along with Road to Tokyo, the Museum also opened a new exhibit on the US Merchant Marine. LTJG Ralph E. Crump Merchant Marine Gallery is a stand-alone gallery that honors the mariners who risked their lives transporting weapons, men and matériel to distant warfronts. Features include a video, artifacts, a model of a Liberty ship and an engaging array of personal narratives. The gallery is situated in the Solomon Victory Theater complex, at the end of the American Spirit Bridge – a new glass-and-metal bridge that connects the Museum’s Louisiana Memorial Pavilion with the rest of the six-acre campus for the first time.
To view the multimedia release go to:
http://www.multivu.com/players/English/7710051-national-wwii-museum-road-to-tokyo/
The Crespo family of Detroit, Mich. was named winner of the third annual National Family PLUS Cook-off, which was hosted at Bradford’s on Bishop in Atlanta by Boys & Girls Clubs of America (BGCA) and Kimberly-Clark Corporation on Wednesday, Nov. 17. Families representing Boys & Girls Clubs from around the nation competed in regional events to qualify for the national cook-off. Finalists represented Clubs from Harbor City, Calif.; Pittsburgh, Pa.; Detroit, Mich.; Bluffton, S.C.; and Swink, Okla.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bgca/47039/
CHUYÊN SẢN XUẤT MÁY THEO YÊU CẦU. ĐÁP ỨNG ĐƯỢC NHIỀU LOẠI MÁY THÔNG DỤNG CÓ CHIỀU DÀI MÁY TỪ 1M8 ĐẾN 7M5.
(Tham khảo thêm tại www.minhtoan.com.vn hoặc qua điện thoại 0908201776)
Solta Medical's novel addition to its aesthetic device solutions, the Clear + Brilliant pélo™ laser, offers personalized results with groundbreaking laser hair removal [LHR] technology to make it fast and simple with minimal pain for anyone to get rid of unwanted hair.
The Clear + Brilliant pélo™ laser provides a highly effective treatment in a short amount of time due to its innovative linear scanning technology and the largest treatment window in the market. A full back takes only 8-12 minutes, and full legs take about 36 minutes. After 5-6 treatments, patients can see the results they want, and still have money in their pocket for the long run.
Each treatment can be customized depending on the individual's needs, and patient comfort is enhanced by minimizing pain on contact through a sapphire glass handpiece that quickly chills to 0°C. So patients and physicians can rest easy that their individual needs are met.
To view the multimedia release go to:
http://www.multivu.com/players/English/7621831-clear-brilliant-pelo-laser-hair-removal/
